A medication resource for myeloma patients i page 1 800. The nccn recommends cancer patient participation in clinical trials as the gold standard for treatment. According to the american cancer society, more than 30,000 people in the united states will. Myeloma is a cancer of the plasma cells in the bone marrow. Tips for patients before you leave your medical appointment, be sure you understand and have a plan for. Multiple myeloma is a type of cancer that affects plasma cells, which are a part of your immune system. Multiple myeloma early detection, diagnosis, and staging. A plasma cell is a type of immune cell that produces antibodies to fight infection. It is characterized by the uncontrolled growth of clonal plasma cells pcs and leads to. New drugs for multiple myeloma australian prescriber. Virtually every case of mm is preceded by a premalignant pc tumor called monoclonal gammopathy of undetermined significance mgus 6, 7 that, like mm. Multiple myeloma genetic and rare diseases information.
Neurologic complications in multiple myeloma and plasmacytoma. Understanding multiple myeloma, its treatment, and new. The diagnosis and monitoring of patients with nonsecretory myeloma depends on an excess of monoclonal kappa or lambda plasma cells in the bone marrow. Multiple myeloma is a type of blood cancer that affects the plasma cells found in bone marrow. Myeloma is called multiple because it frequently involves multiple areas in the body. Progress and paradigms in multiple myeloma ncbi nih. Bone pain related to multiple lytic lesions is the most. An allogeneic transplant uses donor bone marrow or stem cells to replace the cells destroyed. The patient handbook focuses on the questions and decisions that a newly diagnosed patient faces. As detailed by landgren and rajkumar 5, the definition of multiple myeloma mm has traditionally included excess monoclonal bone marrow bm plasma cells. Patients usually present with hypercalcemia, renal insufficiency, anemia andor. Characteristics and results of the treatment of multiple.
Current multiple myeloma treatment adapted from the nccn. Proteasome inhibitors such as bortezomib and carfilzomib target the ubiquitin pathway, resulting in. We retrospectively studied 30 cases of multiple myeloma in patients under the age of 65, diagnosed from 1991 to 2005 in the clinical hematology department of the university hospital of yopougon that is a. Understanding multiple myeloma, its treatment, and new discoveries.
In the past decade, we have witnessed dramatic changes in the treatment of multiple myeloma. The high dose chemotherapy treats the multiple myeloma. Multiple myeloma is a malignant monoclonal plasma cell disorder characterized by osteolytic bone lesions, anemia, hypercalcemia, and renal failure. Understanding treatment planning in multiple myeloma. Certain trisomies, when there are three instances of a particular chromosome instead of two, significantly improve overall survival in patients with multiple myeloma with del17p or t4. This is measured in the laboratory as paraprotein or free light chains in blood, or bencejones. Multiple myeloma is a disease in which a neoplastic proliferation of plasma cells produces a monoclonal immunoglobulin. Stem cell transplant for multiple myeloma supportive treatments for patients with multiple myeloma common treatment approaches depending on the stage of the cancer, whether or not you are a candidate for a stem cell transplant, and other factors, different types of treatment may be combined at the same time or used after one another. It is defined as monoclonal plasmocytic prolif eration of the bone marrow with the same clinical and radiological manifestations of myeloma. Multiple myeloma treatment regimens part 1 of 9 clinical trials.
Multiple myeloma mm is the most frequent malignant plasma cell disorder, accounting for approximately 10 % of all haematological. In 2015, an estimated 28,850 new cases of multiple myeloma were. It is the second most common blood cancer and is considered incurable. It is almost invariably preceded by premalignant stages of monoclonal gammopathy of undetermined significance mgus and smoldering mm smm, although not all cases of mgus will eventually progress to mm. Patients may present with bone pain or with symptoms that are often nonspecific, such as nausea. Assessing newer treatment approaches for multiply relapsed. Treatment guidelines for newly diagnosed multiple myeloma. Multiple myeloma is a malignant proliferation of plasma cells that characteristically secrete a monoclonal protein. You will read about the scientific research being done now to learn more about multiple myeloma and how to treat it. Putnam and sarah hardy from the department of biochemistry, university of chicago, chicago, illinois received for publication, june 28, 1954 multiple myeloma. Multiple myeloma is a rare, largely incurable malignant disease of plasma cells.
The imfs patient handbook is designed to help you to understand multiple myeloma which we refer to simply as myeloma. Esmoacf patient guide series based on the esmo clinical practice guidelines. Molecular pathogenesis of multiple myeloma request pdf. Current multiple myeloma treatment adapted from the nccn guidelines diagnosis survival 35 yrs survival multiple myeloma the bmj. Current treatment landscape for relapsed andor refractory. Multiple myeloma mm is an incurably disease of the bone marrow. Multiple myeloma is a cancer of your plasma cells, a type of white blood cell present in your bone marrow.
International myeloma working group consensus criteria for response and minimal residual disease assessment in multiple myeloma. New therapies for multiple myeloma provide optimistic outlook. We hope that the information will be helpful to both healthcare professionals and patients. Seifter, md johns hopkins university any comments or questions about the summary content should be. Natural treatments for multiple myeloma positivemed. Multiple myeloma is a haematological malignancy with protean manifestations, producing disease in bones, kidneys and other organs. In the united states, multiple myeloma myeloma, plasma cell myeloma is the third most common hematologic malignancy after lymphoma and leukemia 1 but the 14th most common malignancy. The changing paradigm highdose chemotherapy and stem cell transplantation todd zimmerman, md university of chicago medical center. Multiple myeloma is a malignancy of plasma cells origi nating from the bone marrow. New oral drug in multiple myeloma may be game changer. Treatment of multiple myeloma patients with autologous stem cell transplantation a fresh analysis. Natural killer nk cell therapy for multiple myeloma patients. Bone pain is the most common presenting symptom in mm. Multiple myeloma early detection, diagnosis, and staging cancer.
62 149 987 1448 150 889 59 1362 473 160 781 14 171 1516 1190 640 1 141 1331 781 1114 286 667 854 420 562 877 1497 101 395 111 30 1081 1402 300 1485 134 594 1177 377 692 628